AR and prostate carcinoma: MAGEB2 could bind to the NH2-terminal NTD domain of AR through the F-box in the MAGE homology domain, and promotes prostate cancer cell growth by upregulating its downstream targets PSA and NX3.1 to activate AR signaling [14].